Related Experiment Videos
Medical disorders in pregnancy
1Department of Obstetrics and Gynecology, Sinai Hospital of Detroit, Michigan.
Emergency Medicine Clinics of North America
|August 1, 1987
Summary
Maternal and fetal platelet counts are crucial for managing pregnancy complications. Monitoring platelet levels and considering interventions like steroid therapy or cesarean delivery can improve neonatal outcomes.
Area of Science:
- Perinatology
- Immunology
- Neonatology
Background:
- Management of maternal thrombocytopenia during pregnancy remains controversial.
- Available therapies and diagnostic tools allow for individualized patient management plans.
Purpose of the Study:
- To outline a management strategy for pregnant patients with thrombocytopenia.
- To discuss the role of platelet antibody testing and fetal monitoring in predicting outcomes.
- To evaluate the efficacy of antenatal therapies for neonatal platelet count improvement.
Main Methods:
- Careful monitoring of maternal platelet counts throughout pregnancy.
- Utilizing platelet antibody testing to predict fetal involvement.
- Considering fetal scalp platelet count at labor onset.
- Evaluating the impact of steroid therapy and intravenous immunoglobulin therapy.
Main Results:
- Platelet antibody testing aids in identifying fetuses at risk.
- Fetal scalp platelet counts below 50,000/mm³ necessitate immediate cesarean section.
- Steroid therapy near term shows a beneficial effect on neonatal platelet counts.
- High-dose intravenous immunoglobulin therapy may offer prophylactic benefits.
Conclusions:
- Individualized management plans are essential for pregnant patients with thrombocytopenia.
- Antenatal interventions like steroid therapy and potentially intravenous immunoglobulin can improve neonatal platelet counts.
- Cesarean delivery is indicated in specific fetal platelet count scenarios.